These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36559123)

  • 1. Effect of Dispersion Medium on Pharmacokinetic Profile of Rotigotine Crystalline Suspension following Subcutaneous Injection.
    Kim MS; Ho MJ; Joung MY; Choi YS; Kang MJ
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of Montelukast Nanocrystalline Suspension for Parenteral Prolonged Delivery.
    Park JS; Kim MS; Joung MY; Park HJ; Ho MJ; Choi JH; Seo JH; Song WH; Choi YW; Lee S; Choi YS; Kang MJ
    Int J Nanomedicine; 2022; 17():3673-3690. PubMed ID: 36046838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Assembled Lecithin-Chitosan Nanoparticles Improved Rotigotine Nose-to-Brain Delivery and Brain Targeting Efficiency.
    Saha P; Singh P; Kathuria H; Chitkara D; Pandey MM
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of particle size on in vivo performances of long-acting injectable drug suspension.
    Ho MJ; Jeong MY; Jeong HT; Kim MS; Park HJ; Kim DY; Lee HC; Song WH; Kim CH; Lee CH; Choi YW; Choi YS; Han YT; Kang MJ
    J Control Release; 2022 Jan; 341():533-547. PubMed ID: 34902451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome.
    Elshoff JP; Cawello W; Andreas JO; Mathy FX; Braun M
    Drugs; 2015 Apr; 75(5):487-501. PubMed ID: 25795100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-ergot dopamine agonist rotigotine as a promising therapeutic tool in atypical parkinsonism syndromes: a 24 months pilot observational open-label study.
    Moretti DV; Binetti G; Zanetti O; Frisoni GB
    Neuropharmacology; 2014 Oct; 85():284-9. PubMed ID: 24915072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Rotigotine Transdermal Patch on Neuropsychiatric Symptoms of Parkinson's Disease: An Updated Meta-Analysis and Systematic Review.
    Yan J; Ma H; Liu A; Huang J; Wu J; Yang J
    Front Neurol; 2021; 12():722892. PubMed ID: 34744967
    [No Abstract]   [Full Text] [Related]  

  • 8. Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy.
    Moretti DV; Binetti G; Zanetti O; Frisoni GB
    Neuropsychiatr Dis Treat; 2014; 10():1003-9. PubMed ID: 24940065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical appraisal of rotigotine transdermal system in management of Parkinson's disease and restless legs syndrome - patient considerations.
    Kesayan T; Shaw JD; Jones TM; Staffetti JS; Zesiewicz TA
    Degener Neurol Neuromuscul Dis; 2015; 5():63-72. PubMed ID: 32669913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.
    Cawello W; Kim SR; Braun M; Elshoff JP; Ikeda J; Funaki T
    Clin Drug Investig; 2014 Feb; 34(2):95-105. PubMed ID: 24178238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Delivery and Transport into the Central Circulation: An Example of Zero-Order In vivo Absorption of Rotigotine from a Transdermal Patch Formulation.
    Cawello W; Braun M; Andreas JO
    Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):475-481. PubMed ID: 29332198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies.
    Elshoff JP; Braun M; Andreas JO; Middle M; Cawello W
    Clin Ther; 2012 Apr; 34(4):966-78. PubMed ID: 22401642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotigotine transdermal patch for the treatment of Parkinson's disease and restless legs syndrome.
    Boroojerdi B; Wolff HM; Braun M; Scheller DK
    Drugs Today (Barc); 2010 Jul; 46(7):483-505. PubMed ID: 20683503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsuspension of fatty acid esters of entecavir for parenteral sustained delivery.
    Ho MJ; Lee DR; Im SH; Yoon JA; Shin CY; Kim HJ; Jang SW; Choi YW; Han YT; Kang MJ
    Int J Pharm; 2018 May; 543(1-2):52-59. PubMed ID: 29597034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and in vivo evaluation of entecavir-3-palmitate microcrystals for subcutaneous sustained delivery.
    Ho MJ; Lee DR; Im SH; Yoon JA; Shin CY; Kim HJ; Jang SW; Choi YW; Han YT; Kang MJ
    Eur J Pharm Biopharm; 2018 Sep; 130():143-151. PubMed ID: 29940226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Payload Nanosuspension of
    Kim EA; Park JS; Kim MS; Jeong MY; Park HJ; Choi JH; Seo JH; Choi YS; Kang MJ
    Int J Nanomedicine; 2021; 16():7417-7432. PubMed ID: 34764648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotigotine transdermal system for the treatment of Parkinson's disease.
    Pham DQ; Nogid A
    Clin Ther; 2008 May; 30(5):813-24. PubMed ID: 18555929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine.
    Braun M; Cawello W; Boekens H; Horstmann R
    Br J Clin Pharmacol; 2009 Feb; 67(2):209-15. PubMed ID: 19094160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects.
    Liu Y; Tomlinson B; Guo J; Asgharnejad M; Bauer L; Surmann E; Guo X; Elshoff JP
    Clin Ther; 2018 Jul; 40(7):1108-1121.e8. PubMed ID: 30098648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking
    Nguyen V; Bevernage J; Darville N; Tistaert C; Van Bocxlaer J; Rossenu S; Vermeulen A
    Mol Pharm; 2021 Mar; 18(3):952-965. PubMed ID: 33400546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.